The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:1745-1747 June 8, 2000 Number 23
NextNext

The Role of Transjugular Portosystemic Shunting in Patients with Ascites

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Rössle, M.
-PubMed Citation
Ascites is one of the most important complications of cirrhosis. It predisposes patients to several additional complications, including spontaneous bacterial peritonitis, the hepatorenal syndrome, and hepatic hydrothorax, and it is one of the most common indications for liver transplantation. Ascites is typically managed initially with diuretics and restriction of sodium intake. When this approach fails, the alternatives have been less than ideal. A number of therapies have been tried, including peritoneovenous shunts and side-to-side portocaval shunts, both of which are associated with an unacceptable incidence of severe adverse effects, such as disabling hepatic encephalopathy. More recently, large-volume paracentesis, the transjugular . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.